Drugs / Hepatyrix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00197249 | May 2002 → Jun 2003 | hepatitis A virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatyrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00197249 ↗ |
| Modality | Vaccine | “combined Vi polysaccharide typhoid vaccine” NCT00197249 ↗ |
| Route | Intramuscular | “administered intramuscularly to healthy subjects aged 18-65 yrs” NCT00197249 ↗ |